A new study reveals that dapagliflozin, a common diabetes medication, could significantly improve conditions like metabolic ...

The sodium glucose cotransporter 2 (SGLT-2) inhibitor drug dapagliflozin, widely used to treat type 2 diabetes, also shows ...

NASH becomes MASH as medical experts replace stigmatizing "non-alcoholic" liver disease terminology with dignity-focused ...

Metabolic dysfunction–associated steatohepatitis (MASH) is the new term for non-alcoholic steatohepatitis (NASH). There are ...

Improves fibrosis and steatohepatitis Metabolic dysfunction-associated steatotic liver disease (MASLD) encompasses a broad clinical spectrum, ranging from simple steatosis to metabolic ...

Currently, the only approved treatment for MASH on the market is the thyroid hormone receptor β agonist resmetirom (Rezdiffra ...

Fat cells are also metabolically active and can cause a chronic state of inflammation in the part of the body where they ...

Modern unhealthy lifestyles and dietary habits have led to a yearly increase in the incidence of metabolism-related liver ...

An international study reveals that the drug can reverse liver damage in patients. An international study led by researchers ...

A new American Diabetes Association consensus statement provides guidance on screening, diagnosing, and managing metabolic ...